IGF1 and Alzheimer disease: In terms of the underlying mechanisms, on the one hand, IGF-1 deficiency may enhance oxidative stress in endothelial cells and astrocytes, leading to neurovascular uncoupling in AD [32]; on the other hand, IGF-1 can increase amyloid-β clearance by enhancing transport of amyloid-β-carrier proteins into the brain [9].